Norris Medicines Closes Trading Window for Insider Trading

Norris Medicines Ltd has announced the closure of its trading window for designated persons, including promoters, directors, auditors, and key managerial personnel, effective October 1, 2026. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and will remain in effect until 48 hours after the declaration of the un-audited financial results for the quarter ending September 30, 2026. The company will announce the date of the board meeting to approve these results in due course. Designated individuals are prohibited from trading in the company's securities during this period.